Iveric Bio

$8.87 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Iveric Bio

IVERIC bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. IVERIC bio serves customers in the United States.

Stock Analysis

last close $8.95
1-mo return 52.7%
3-mo return 41.8%
avg daily vol. 3.39M
52-week high 10.25
52-week low 3.97
market cap. $913M
forward pe -
annual div. -
roe -70.8%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 85.4%

Subscribe now for daily local and international financial news